Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: B cell targeted therapy: a new approach to the treatment of rheumatoid arthritis

Highly Access

Unmet needs in rheumatoid arthritis

Larry Moreland

Arthritis Research & Therapy 2005, 7(Suppl 3):S2-S8 doi:10.1186/ar1736

Accesses  

  • Last 30 days: 78 accesses
  • Last 365 days: 670 accesses
  • All time: 7628 accesses

Cited by

BioMed Central: 1 citation

Research article   Open Access Highly Accessed

Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis

Gabor Erős, Saleh Ibrahim, Nikolai Siebert, Mihály Boros, Brigitte Vollmar Arthritis Research & Therapy 2009, 11:R43 (18 March 2009)